Liposome Assisted Drug Delivery Market, Global Outlook and Forecast 2023-2028

Report ID: 1568104 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Liposome Assisted Drug Delivery Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Liposome Assisted Drug Delivery Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Liposome Assisted Drug Delivery Overall Market Size
    2.1 Global Liposome Assisted Drug Delivery Market Size: 2021 VS 2028
    2.2 Global Liposome Assisted Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Liposome Assisted Drug Delivery Players in Global Market
    3.2 Top Global Liposome Assisted Drug Delivery Companies Ranked by Revenue
    3.3 Global Liposome Assisted Drug Delivery Revenue by Companies
    3.4 Top 3 and Top 5 Liposome Assisted Drug Delivery Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Liposome Assisted Drug Delivery Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Liposome Assisted Drug Delivery Players in Global Market
        3.6.1 List of Global Tier 1 Liposome Assisted Drug Delivery Companies
        3.6.2 List of Global Tier 2 and Tier 3 Liposome Assisted Drug Delivery Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Liposome Assisted Drug Delivery Market Size Markets, 2021 & 2028
        4.1.2 Liposomal Doxorubicin
        4.1.3 Liposomal Amphoteracin B
        4.1.4 Liposomal Paclitaxel
        4.1.5 Others
    4.2 By Type - Global Liposome Assisted Drug Delivery Revenue & Forecasts
        4.2.1 By Type - Global Liposome Assisted Drug Delivery Revenue, 2017-2022
        4.2.2 By Type - Global Liposome Assisted Drug Delivery Revenue, 2023-2028
        4.2.3 By Type - Global Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Liposome Assisted Drug Delivery Market Size, 2021 & 2028
        5.1.2 Fungal Infection Therapy
        5.1.3 Cancer & Tumor Therapy
        5.1.4 Others
    5.2 By Application - Global Liposome Assisted Drug Delivery Revenue & Forecasts
        5.2.1 By Application - Global Liposome Assisted Drug Delivery Revenue, 2017-2022
        5.2.2 By Application - Global Liposome Assisted Drug Delivery Revenue, 2023-2028
        5.2.3 By Application - Global Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Liposome Assisted Drug Delivery Market Size, 2021 & 2028
    6.2 By Region - Global Liposome Assisted Drug Delivery Revenue & Forecasts
        6.2.1 By Region - Global Liposome Assisted Drug Delivery Revenue, 2017-2022
        6.2.2 By Region - Global Liposome Assisted Drug Delivery Revenue, 2023-2028
        6.2.3 By Region - Global Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Liposome Assisted Drug Delivery Revenue, 2017-2028
        6.3.2 US Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.3.3 Canada Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.3.4 Mexico Liposome Assisted Drug Delivery Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Liposome Assisted Drug Delivery Revenue, 2017-2028
        6.4.2 Germany Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.4.3 France Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.4.4 U.K. Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.4.5 Italy Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.4.6 Russia Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.4.7 Nordic Countries Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.4.8 Benelux Liposome Assisted Drug Delivery Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Liposome Assisted Drug Delivery Revenue, 2017-2028
        6.5.2 China Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.5.3 Japan Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.5.4 South Korea Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.5.5 Southeast Asia Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.5.6 India Liposome Assisted Drug Delivery Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Liposome Assisted Drug Delivery Revenue, 2017-2028
        6.6.2 Brazil Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.6.3 Argentina Liposome Assisted Drug Delivery Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Liposome Assisted Drug Delivery Revenue, 2017-2028
        6.7.2 Turkey Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.7.3 Israel Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.7.4 Saudi Arabia Liposome Assisted Drug Delivery Market Size, 2017-2028
        6.7.5 UAE Liposome Assisted Drug Delivery Market Size, 2017-2028
7 Players Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Corporate Summary
        7.1.2 Gilead Sciences Business Overview
        7.1.3 Gilead Sciences Liposome Assisted Drug Delivery Major Product Offerings
        7.1.4 Gilead Sciences Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.1.5 Gilead Sciences Key News
    7.2 Pacira
        7.2.1 Pacira Corporate Summary
        7.2.2 Pacira Business Overview
        7.2.3 Pacira Liposome Assisted Drug Delivery Major Product Offerings
        7.2.4 Pacira Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.2.5 Pacira Key News
    7.3 Sun Pharmaceutical
        7.3.1 Sun Pharmaceutical Corporate Summary
        7.3.2 Sun Pharmaceutical Business Overview
        7.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Major Product Offerings
        7.3.4 Sun Pharmaceutical Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.3.5 Sun Pharmaceutical Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Major Product Offerings
        7.4.4 Johnson & Johnson Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 Luye Pharma
        7.5.1 Luye Pharma Corporate Summary
        7.5.2 Luye Pharma Business Overview
        7.5.3 Luye Pharma Liposome Assisted Drug Delivery Major Product Offerings
        7.5.4 Luye Pharma Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.5.5 Luye Pharma Key News
    7.6 Sigma-Tau Group
        7.6.1 Sigma-Tau Group Corporate Summary
        7.6.2 Sigma-Tau Group Business Overview
        7.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Major Product Offerings
        7.6.4 Sigma-Tau Group Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.6.5 Sigma-Tau Group Key News
    7.7 Ipsen (Onivyde)
        7.7.1 Ipsen (Onivyde) Corporate Summary
        7.7.2 Ipsen (Onivyde) Business Overview
        7.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Major Product Offerings
        7.7.4 Ipsen (Onivyde) Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.7.5 Ipsen (Onivyde) Key News
    7.8 CSPC
        7.8.1 CSPC Corporate Summary
        7.8.2 CSPC Business Overview
        7.8.3 CSPC Liposome Assisted Drug Delivery Major Product Offerings
        7.8.4 CSPC Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.8.5 CSPC Key News
    7.9 Teva Pharmaceutical
        7.9.1 Teva Pharmaceutical Corporate Summary
        7.9.2 Teva Pharmaceutical Business Overview
        7.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Major Product Offerings
        7.9.4 Teva Pharmaceutical Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.9.5 Teva Pharmaceutical Key News
    7.10 Novartis
        7.10.1 Novartis Corporate Summary
        7.10.2 Novartis Business Overview
        7.10.3 Novartis Liposome Assisted Drug Delivery Major Product Offerings
        7.10.4 Novartis Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.10.5 Novartis Key News
    7.11 Fudan-Zhangjiang
        7.11.1 Fudan-Zhangjiang Corporate Summary
        7.11.2 Fudan-Zhangjiang Business Overview
        7.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Major Product Offerings
        7.11.4 Fudan-Zhangjiang Liposome Assisted Drug Delivery Revenue in Global Market (2017-2022)
        7.11.5 Fudan-Zhangjiang Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Liposome Assisted Drug Delivery Market Opportunities & Trends in Global Market
    Table 2. Liposome Assisted Drug Delivery Market Drivers in Global Market
    Table 3. Liposome Assisted Drug Delivery Market Restraints in Global Market
    Table 4. Key Players of Liposome Assisted Drug Delivery in Global Market
    Table 5. Top Liposome Assisted Drug Delivery Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Liposome Assisted Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Liposome Assisted Drug Delivery Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Liposome Assisted Drug Delivery Product Type
    Table 9. List of Global Tier 1 Liposome Assisted Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Liposome Assisted Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Liposome Assisted Drug Delivery Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Liposome Assisted Drug Delivery Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Liposome Assisted Drug Delivery Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Liposome Assisted Drug Delivery Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Liposome Assisted Drug Delivery Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Liposome Assisted Drug Delivery Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2023-2028
    Table 30. Gilead Sciences Corporate Summary
    Table 31. Gilead Sciences Liposome Assisted Drug Delivery Product Offerings
    Table 32. Gilead Sciences Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 33. Pacira Corporate Summary
    Table 34. Pacira Liposome Assisted Drug Delivery Product Offerings
    Table 35. Pacira Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 36. Sun Pharmaceutical Corporate Summary
    Table 37. Sun Pharmaceutical Liposome Assisted Drug Delivery Product Offerings
    Table 38. Sun Pharmaceutical Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Liposome Assisted Drug Delivery Product Offerings
    Table 41. Johnson & Johnson Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 42. Luye Pharma Corporate Summary
    Table 43. Luye Pharma Liposome Assisted Drug Delivery Product Offerings
    Table 44. Luye Pharma Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 45. Sigma-Tau Group Corporate Summary
    Table 46. Sigma-Tau Group Liposome Assisted Drug Delivery Product Offerings
    Table 47. Sigma-Tau Group Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 48. Ipsen (Onivyde) Corporate Summary
    Table 49. Ipsen (Onivyde) Liposome Assisted Drug Delivery Product Offerings
    Table 50. Ipsen (Onivyde) Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 51. CSPC Corporate Summary
    Table 52. CSPC Liposome Assisted Drug Delivery Product Offerings
    Table 53. CSPC Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 54. Teva Pharmaceutical Corporate Summary
    Table 55. Teva Pharmaceutical Liposome Assisted Drug Delivery Product Offerings
    Table 56. Teva Pharmaceutical Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 57. Novartis Corporate Summary
    Table 58. Novartis Liposome Assisted Drug Delivery Product Offerings
    Table 59. Novartis Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
    Table 60. Fudan-Zhangjiang Corporate Summary
    Table 61. Fudan-Zhangjiang Liposome Assisted Drug Delivery Product Offerings
    Table 62. Fudan-Zhangjiang Liposome Assisted Drug Delivery Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Liposome Assisted Drug Delivery Segment by Type in 2021
    Figure 2. Liposome Assisted Drug Delivery Segment by Application in 2021
    Figure 3. Global Liposome Assisted Drug Delivery Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Liposome Assisted Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Liposome Assisted Drug Delivery Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2021
    Figure 8. By Type - Global Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 12. US Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 16. Germany Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 17. France Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 24. China Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 28. India Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 30. Brazil Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Liposome Assisted Drug Delivery Revenue Market Share, 2017-2028
    Figure 33. Turkey Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Liposome Assisted Drug Delivery Revenue, (US$, Mn), 2017-2028
    Figure 37. Gilead Sciences Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pacira Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Sun Pharmaceutical Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Luye Pharma Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Sigma-Tau Group Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Ipsen (Onivyde) Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. CSPC Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Teva Pharmaceutical Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Novartis Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Fudan-Zhangjiang Liposome Assisted Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Liposome Assisted Drug Delivery Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liposome Assisted Drug Delivery Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liposome Assisted Drug Delivery Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports